← Open Payments lookup

GREGORY BROWN: Open Payments

NPI 1821058181 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$117,397 in 202 payments from 10 companies in 2025. Trend: 2023 $95,084 · 2024 $80,693 · 2025 $117,397

Speaker / faculty: $73,734Honoraria: $24,250Travel & lodging: $7,703Consulting: $6,888Food & beverage: $4,800Education: $22
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.56$41,844
Supernus Pharmaceuticals, Inc.45$28,365
Neurocrine BioSciences, Inc.31$26,306
ABBVIE INC.32$19,690
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$394
Alkermes, Inc.14$270
Axsome Therapeutics, Inc.3$257
E.R. Squibb & Sons, L.L.C.5$185
Lundbeck LLC3$63
Corium, LLC1$23

Products named: REXULTI, Qelbree, INGREZZA, VRAYLAR, CAPLYTA, ARISTADA, Auvelity, COBENFY.

Industry payments across LA — which companies pay providers there.